Pharmaceutical companies make huge investments in equipment, materials, and personnel to develop and manufacture life-saving products. The equipment that makes those products is designed, manufactured, and commissioned to a specific set of standards. There is an expectation that the equipment will continue to provide quality service within those parameters for…
In many ways, today’s pharma and biotech facilities share the same problem that many of the factories that supported the war effort during World War II had – a shortage of skilled and qualified operators and technicians. This lack of a skilled workforce in the early 1940’s was a crisis…
Sometimes projects are conducted as a series of disconnected efforts where each team from planning, design, construction, and testing views themselves as separate entities. With each trying to finish their portion of the work and get on to their next project. These “separate” efforts have goals to accomplish, and sometimes…
Overview Until about 2016, the majority of vectors used in gene therapy were Adenovirus and Retrovirus vectors. In recent years, a change toward Lentivirus and Adeno-associated virus (AAV) vectors has occurred. This is reflected when looking at the numbers in current clinical trials underway in the gene therapy field.
Predictive Maintenance (PdM) technologies are not just for use after your equipment has been installed. Many of these technologies can be applied during the various stages of your commissioning activities.
“The ultimate goal of providing a robust, safe method to transfer solutions in the Manufacturing Facility was achieved and CAI played a major role with this safety initiative.”
INDUSTRY RESOURCES
Download articles and resources from industry events and publications.
